FractalMed

FractalMed is a company developing biomarkers for nervous system diseases. It provides a medical software to enable early detection of brain disorder in brain resonance imaging in normal appearing. The technology can be applied in MRI related to multiple sclerosis, Alzheimer, Parkinson, and other neurodegenerative pathologies.